DemTect: 1-year experience of a neuropsychological screening test for dementia [2]

Age and Ageing

Volumn 36, Issue 3, 2007, Pages 326-327

  Larner, A J ^a  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; PREVALENCE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SENSITIVITY AND SPECIFICITY; AREA UNDER THE CURVE; ARTICLE; EVALUATION; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT ATTITUDE; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; ROC CURVE; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; DEMENTIA; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; MALE; MASS SCREENING; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PATIENT ACCEPTANCE OF HEALTH CARE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 34250670439     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afl183     Document Type: Letter

References (5)

1. Kalbe E, Kessler J, Calabrese P et al. DemTect: A new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry 2004; 19: 136-43.
2. Gifford DR, Cummings JL. Evaluating dementia screening tests. Methodologic standards to rate their performance. Neurology 1999; 52: 224-7.
3. Qizilbash N. Evidence-based diagnosis. In: Qizilbash N, Schneider LS, Chui H et al, eds. Evidence-based Dementia Practice. Oxford: Blackwell, 2002; 18-25.
4. Larner AJ. An audit of the Addenbrooke's Cognitive Examination (ACE) in clinical practice. Int J Geriatr Psychiatry 2005; 20: 593-4.
5. Scheurich A, Muller MJ, Slessmeier T et al. Validating the DemTect with 18-fluoro-2-deoxy-glucose positron emission tomography as a sensitive neuropsychological screening test for early Alzheimer disease in patients of a memory clinic. Dement Geriatr Cogn Disord 2005; 20: 271-7.